Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Liver Diseases

arginyl-glycyl-aspartic acid has been researched along with Liver Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Froh, M; Rusyn, I; Thurman, RG; Wheeler, MD; Yamashina, S1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Liver Diseases

ArticleYear
Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production.
    Journal of leukocyte biology, 2001, Volume: 69, Issue:4

    Topics: Adenoviridae; Animals; Cells, Cultured; Cytokines; DNA-Binding Proteins; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; I-kappa B Proteins; Integrins; Interleukin-10; Kupffer Cells; Lipopolysaccharides; Liver Diseases; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Oligopeptides; Oxidants; Rats; Rats, Sprague-Dawley; Receptors, Virus; Receptors, Vitronectin; Recombinant Fusion Proteins; Superoxide Dismutase; Superoxides; Transcription, Genetic; Transfection; Transgenes; Tumor Necrosis Factor-alpha

2001